Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006
FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005
Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction? Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Is the forced expiratory volume in 6 seconds (FEV6 ) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients Source: Eur Respir J 2001; 18: Suppl. 33, 13s Year: 2001
Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
Comparison between peak expiratory flow rate (PEFR) and FEV1 in the monitoring of children suspected to asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002
Reference values for FEV1, FVC and FEV1/FVC in Norway Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
The effect of stop smoking on FEV1 and FEV1/FVC Source: Eur Respir J 2003; 22: Suppl. 45, 307s Year: 2003
FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace Source: Eur Respir J 2006; 27: 374-377 Year: 2006
Re-assessing the importance of FEV1 decline Source: Eur Respir Monogr 2015; 69: 134-142 Year: 2015
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 225s Year: 2004
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003